Skip to main content

Syra Health Corp

corporate_fare Company Profile

Syra Health Corp

SYRA·OTC·Trade & Services·CIK 0001922335

Syra Health is an integrated healthcare solutions company that provides prevention-focused, accessible, and affordable solutions to government and commercial healthcare organizations to improve health outcomes. The company offers end-to-end capabilities in population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. In Behavioral and Mental Health, Syra Health aims to provide solutions that improve healthcare and access for all populations. The company serves health organizations, large employers, and schools. Syrenity, a comprehensive mental health application, was launched in the third quarter of 2024. Syrenity provides preventative care and interventions for behavioral and mental health, utilizing an artificial intelligence-driven user diary for engagement. It is designed to identify and prevent the progression of negative factors influencing mental health by offering targeted assignments, education, symptom monitoring, and timely interventions like cognitive behavioral therapy and mindfulness techniques. Syrenity enables users to connect with licensed mental health professionals, schedule virtual consultations with psychologists, psychiatrists, or mental health coaches, and provides educational resources for understanding mental health concerns and learning coping strategies. In Population Health, Syra Health assesses and analyzes healthcare and its delivery to create improvements for populations. The company develops end-to-end solutions and strategies to improve quality of care, access to care, health outcomes, and healthcare policies, aiming to assist individuals in reaching their full health potential through preventative care, care coordination, and patient engagement.

Syra Health Corp (OTC:SYRA) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 13 items for SYRA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-11, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for SYRA spans 10-Q, 8-K, DEFA14A, DEF 14A.

Recent high-impact activity:

  • Syra Health Delivers a Second Straight Profitable Quarter but Warns Its Survival Is at Risk
  • Syra Health Posts Second Straight Profitable Quarter, Revenue Up 23%
  • Syra Health Seeks Shareholder Approval for 34% Equity Incentive Plan Increase
  • Syra Health Seeks Shareholder Approval for Significant Equity Plan Expansion
  • Syra Health Reports First Profitable Quarter in Q1 2026 with Strong Revenue Growth and Improved Margins

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$7.23M
Net Income
-$896.33K
Diluted EPS
-$0.08
Op. Cash Flow
-$447.75K
Free Cash Flow
-$447.85K
Gross Profit
$2.49M
Operating Income
-$904.32K
Cash & Equivalents
$1.61M
Debt / Equity
0.00×
Net Margin
-12.4%
Shares Outstanding
11.85M sh
Source: 10-K · filed 2026-04-25 · accession 0001493152-26-019010

Short Interest & Short Volume

5.12 days to cover

FINRA reported short interest of 447,723 shares in SYRA as of the September 15, 2026 settlement, a 16.5% increase from the prior period — about 5.1 days to cover at its recent average daily volume. On October 2, 2026, 13.6% of SYRA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)447,723 shares as of September 15, 2026
Change vs prior period▲ 16.5%
Days to cover5.12 at avg daily volume of 87,369
Daily short volume (FINRA facilities)13.6% of 7,740 shares on October 2, 2026
5-day average short volume31.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for SYRA, detected from its recent SEC filings.

1 shelf registration

Resale Registration for Series B Warrants · Warrant Terms

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with S →
$0.8251 -0.07% today
52-week range · as of 2026-08-11 $0.052 – $1.15
Market cap
$11.72M
Volume
7.7K (0.2× avg)
3-mo avg 33.5K
Live data · 2026-10-05 02:50 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SYRA - Latest Insights

SYRA
Aug 11, 2026, 5:25 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.870
Real-time Price: $0.8251 info
Change: -$0.0449 (-5%) info
Market Cap: $11.717M info
SYRA
Aug 11, 2026, 8:37 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.66495
Real-time Price: $0.8251 info
Change: +$0.16015 (+24%) info
Market Cap: $11.717M info
SYRA
Jun 01, 2026, 4:45 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $0.5023
Real-time Price: $0.8251 info
Change: +$0.3228 (+64%) info
Market Cap: $11.717M info
SYRA
Jun 01, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.5023
Real-time Price: $0.8251 info
Change: +$0.3228 (+64%) info
Market Cap: $11.717M info
SYRA
May 07, 2026, 5:25 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.500265
Real-time Price: $0.8251 info
Change: +$0.324835 (+65%) info
Market Cap: $11.717M info
SYRA
May 07, 2026, 8:16 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4478
Real-time Price: $0.8251 info
Change: +$0.3773 (+84%) info
Market Cap: $11.717M info
SYRA
May 07, 2026, 7:55 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.4478
Real-time Price: $0.8251 info
Change: +$0.3773 (+84%) info
Market Cap: $11.717M info
SYRA
Apr 24, 2026, 9:55 PM EDT
Filing Type: 10-K/A
Importance Score:
7
Price at Filing: $0.470
Real-time Price: $0.8251 info
Change: +$0.3551 (+76%) info
Market Cap: $11.717M info
SYRA
Apr 02, 2026, 5:28 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.239172
Real-time Price: $0.8251 info
Change: +$0.585928 (+245%) info
Market Cap: $11.717M info
SYRA
Mar 12, 2026, 5:25 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.105
Real-time Price: $0.8251 info
Change: +$0.7201 (+686%) info
Market Cap: $11.717M info
SYRA
Mar 12, 2026, 9:29 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.100
Real-time Price: $0.8251 info
Change: +$0.7251 (+725%) info
Market Cap: $11.717M info
SYRA
Mar 12, 2026, 7:55 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.100
Real-time Price: $0.8251 info
Change: +$0.7251 (+725%) info
Market Cap: $11.717M info
SYRA
Jan 16, 2026, 1:56 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $0.081
Real-time Price: $0.8251 info
Change: +$0.7441 (+919%) info
Market Cap: $11.717M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets